Search research articles
Contact Us
Filters
Showing results (251-260 of 265) with videos related to
Page
of 27
Sort By:
Plos Medicine
|
May 22, 2014
Gene-lifestyle interaction and type 2 diabetes: the EPIC interact case-cohort study
Claudia Langenberg, Stephen J Sharp, Paul W Franks, et al.
Journal of the American Heart Association
|
November 19, 2021
Dietary Fatty Acids, Macronutrient Substitutions, Food Sources and Incidence of Coronary Heart Disease: Findings From the EPIC-CVD Case-Cohort Study Across Nine European Countries
Marinka Steur, Laura Johnson, Stephen J Sharp, et al.
Plos Medicine
|
June 9, 2012
Long-term risk of incident type 2 diabetes and measures of overall and regional obesity: the EPIC-InterAct case-cohort study
, Claudia Langenberg, Stephen J Sharp, et al.
Diabetes
|
June 21, 2014
Common genetic variants highlight the role of insulin resistance and body fat distribution in type 2 diabetes, independent of obesity
Robert A Scott, Tove Fall, Dorota Pasko, et al.
The Lancet. Diabetes & Endocrinology
|
August 22, 2024
Meat consumption and incident type 2 diabetes: an individual-participant federated meta-analysis of 1·97 million adults with 100 000 incident cases from 31 cohorts in 20 countries
Chunxiao Li, Tom R P Bishop, Fumiaki Imamura, et al.
BMJ (Clinical Research Ed.)
|
July 27, 2019
Quality of dietary fat and genetic risk of type 2 diabetes: individual participant data meta-analysis
Jordi Merino, Marta Guasch-Ferré, Christina Ellervik, et al.
Plos Medicine
|
November 10, 2011
Physical activity attenuates the influence of FTO variants on obesity risk: a meta-analysis of 218,166 adults and 19,268 children
Tuomas O Kilpeläinen, Lu Qi, Soren Brage, et al.
Lancet (London, England)
|
September 29, 2014
HMG-coenzyme A reductase inhibition, type 2 diabetes, and bodyweight: evidence from genetic analysis and randomised trials
Daniel I Swerdlow, David Preiss, Karoline B Kuchenbaecker, et al.
Science Translational Medicine
|
June 3, 2016
A genomic approach to therapeutic target validation identifies a glucose-lowering GLP1R variant protective for coronary heart disease
Robert A Scott, Daniel F Freitag, Li Li, et al.
BMJ (Clinical Research Ed.)
|
July 12, 2014
Association between alcohol and cardiovascular disease: Mendelian randomisation analysis based on individual participant data
Michael V Holmes, Caroline E Dale, Luisa Zuccolo, et al.
Page
of 27
Search research articles
Search
Showing results (251-260 of 265) with videos related to
Sort By:
Page
of 27
Plos Medicine
|
May 22, 2014
Gene-lifestyle interaction and type 2 diabetes: the EPIC interact case-cohort study
Claudia Langenberg, Stephen J Sharp, Paul W Franks, et al.
Journal of the American Heart Association
|
November 19, 2021
Dietary Fatty Acids, Macronutrient Substitutions, Food Sources and Incidence of Coronary Heart Disease: Findings From the EPIC-CVD Case-Cohort Study Across Nine European Countries
Marinka Steur, Laura Johnson, Stephen J Sharp, et al.
Plos Medicine
|
June 9, 2012
Long-term risk of incident type 2 diabetes and measures of overall and regional obesity: the EPIC-InterAct case-cohort study
, Claudia Langenberg, Stephen J Sharp, et al.
Diabetes
|
June 21, 2014
Common genetic variants highlight the role of insulin resistance and body fat distribution in type 2 diabetes, independent of obesity
Robert A Scott, Tove Fall, Dorota Pasko, et al.
The Lancet. Diabetes & Endocrinology
|
August 22, 2024
Meat consumption and incident type 2 diabetes: an individual-participant federated meta-analysis of 1·97 million adults with 100 000 incident cases from 31 cohorts in 20 countries
Chunxiao Li, Tom R P Bishop, Fumiaki Imamura, et al.
BMJ (Clinical Research Ed.)
|
July 27, 2019
Quality of dietary fat and genetic risk of type 2 diabetes: individual participant data meta-analysis
Jordi Merino, Marta Guasch-Ferré, Christina Ellervik, et al.
Plos Medicine
|
November 10, 2011
Physical activity attenuates the influence of FTO variants on obesity risk: a meta-analysis of 218,166 adults and 19,268 children
Tuomas O Kilpeläinen, Lu Qi, Soren Brage, et al.
Lancet (London, England)
|
September 29, 2014
HMG-coenzyme A reductase inhibition, type 2 diabetes, and bodyweight: evidence from genetic analysis and randomised trials
Daniel I Swerdlow, David Preiss, Karoline B Kuchenbaecker, et al.
Science Translational Medicine
|
June 3, 2016
A genomic approach to therapeutic target validation identifies a glucose-lowering GLP1R variant protective for coronary heart disease
Robert A Scott, Daniel F Freitag, Li Li, et al.
BMJ (Clinical Research Ed.)
|
July 12, 2014
Association between alcohol and cardiovascular disease: Mendelian randomisation analysis based on individual participant data
Michael V Holmes, Caroline E Dale, Luisa Zuccolo, et al.
Page
of 27